Table 1.
Correlation of galectin-1 with the histopathological parameters of HCC patients
| Histopathological parameters | T/NT < 2 (without Gal-1 overexpression) |
T/NT ≥ 2 (with Gal-1 overexpression) |
P-value |
|---|---|---|---|
| Sex | |||
| Male | 47 | 23 | 0.794 |
| Female | 13 | 8 | |
| Cirrhotic liver | |||
| Cirrhosis | 18 | 6 | 0.402 |
| NT & hepatitis | 22 | 14 | |
| HBsAg | |||
| Positive | 38 | 16 | 0.712 |
| Negative | 6 | 4 | |
| Cellular differentiation | |||
| Poor | 22 | 8 | 0.130 |
| Differentiated | 18 | 12 | |
| Tumor size | |||
| > 5 cm | 26 | 15 | 0.560 |
| ≤ 5 cm | 14 | 5 | |
| Tumor encapsulation | |||
| Absent | 21 | 16 | 0.008* |
| Present | 27 | 4 | |
| Venous invasion | |||
| Present | 27 | 19 | 0.270 |
| Absent | 29 | 12 | |
| Microsatellite | |||
| Present | 17 | 15 | 0.032* |
| Absent | 25 | 6 | |
| Direct liver invasion | |||
| Present | 11 | 7 | 0.551 |
| Absent | 23 | 10 | |
| Tumor nodule | |||
| N ≥ 2 | 10 | 7 | 0.547 |
| N = 1 | 29 | 13 | |
T Tumorous, NT non-tumorous, N number of tumor nodule, HBsAg Hepatitis B surface antigen, P < 0.05 is regarded as statistically significant
*P < 0.05 is regarded as statistically significant